Eko receives FDA clearance for heart murmur analysis algorithm
Eko Murmur Analysis Software is a machine learning algorithm that detects and characterizes heart murmurs in adult and pediatric patients.
Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eko Murmur Analysis Software is a machine learning algorithm that detects and characterizes heart murmurs in adult and pediatric patients.
The partnership will focus on software that uses ECGs to find left ventricular dysfunction and atherosclerotic cardiovascular disease.
The startup announced a $5.5 million Series A raise in May 2021.
Anumana and Novartis Pharmaceuticals Corporation have partnered to use artificial intelligence (AI) for the detection of heart diseases.
Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease